Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Partnology is a biotech growth and investment firm founded in 2019 and headquartered in Southern California. The firm specializes in assembling teams and investing in early-stage biotech companies, particularly those focused on developing innovative therapies for underserved patient populations. Partnology's approach integrates capital investment with a strong emphasis on executive search and company building.
Since its inception, Partnology has positioned itself as a key player in the biotech sector, leveraging a network of venture firms, strategic investors, and industry professionals to support the growth of its portfolio companies. Although specific quantitative metrics such as assets under management (AUM) or fund sizes are not disclosed, the firm is dedicated to fostering the next generation of biotech unicorns through strategic investments and operational support.
Partnology invests primarily in early-stage biotech companies, specifically targeting the pre-seed, seed, and seed-plus stages. The firm emphasizes its commitment to addressing the needs of underserved patient populations, which shapes its investment thesis. Partnology combines capital investment with expertise in executive search and company building, ensuring that portfolio companies receive not only financial backing but also strategic guidance.
The firm operates mainly in North America and engages with a network of venture firms and strategic investors to enhance the growth potential of its investments. Partnology seeks founders who are passionate about their missions and possess the capability to drive innovation in the biotech space.
Partnology's portfolio consists of various biotech companies, although specific names and descriptions are not provided in the available data. The firm emphasizes its role in helping to build the next generation of biotech unicorns through strategic investments and support. This includes a focus on companies that are developing therapies for underserved patient populations, aligning with Partnology's investment thesis.
While the exact number of portfolio companies is not disclosed, the firm is actively involved in the biotech sector, indicating a diverse range of investments aimed at addressing critical healthcare challenges.
Ellie Laidlaw: Co-founder, Executive Search & Investment Practice. Ellie has extensive experience in executive search and investment, focusing on building strong teams for biotech companies.
John Mcintyre: Co-founder, Executive Search & Investment Practice. John brings a wealth of knowledge in investment strategies and company building within the biotech sector.
Meghan Medrick: Director of Research & Market Insights. Meghan specializes in market analysis and insights, providing valuable data to inform investment decisions.
Startups interested in pitching to Partnology should do so through their website. It is recommended to include a comprehensive deck that outlines the business model, team, and market opportunity. Response times may vary, so founders should be prepared for potential follow-up discussions.
Partnology has been actively sharing insights through blog posts that highlight significant funding rounds and industry developments in the biotech sector. Recent topics covered include major fundraising events, IPO filings, and FDA approvals, indicating ongoing engagement with the biotech community.
The firm continues to position itself as a thought leader in the biotech investment space, contributing to discussions around innovative therapies and the future of healthcare.
What are Partnology's investment criteria?
Partnology focuses on early-stage biotech companies, particularly those that address underserved patient populations. The firm looks for innovative therapies and strong founding teams capable of executing their vision.
How can startups apply or pitch to Partnology?
Startups can pitch to Partnology through their website at partnology.com. It is advisable to include a detailed business plan and information about the team and product.
What makes Partnology different from other biotech investors?
Partnology combines capital investment with expertise in executive search and company building, providing portfolio companies with strategic support beyond just funding.
What is the geographic scope of Partnology's investments?
The firm primarily invests in North America, focusing on biotech companies that are developing innovative therapies.
What is Partnology's approach to post-investment involvement?
Partnology actively engages with its portfolio companies, offering support in executive search and operational strategy to help them scale effectively.
What is the typical check size for investments made by Partnology?
While specific check sizes are not disclosed, Partnology focuses on early-stage investments, which typically range from pre-seed to seed-plus funding rounds.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.